Literature DB >> 22508371

Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis.

E Boleslawski1, G Petrovai, S Truant, S Dharancy, A Duhamel, J Salleron, P Deltenre, G Lebuffe, P Mathurin, F R Pruvot.   

Abstract

BACKGROUND: Preoperative measurement of hepatic venous pressure gradient (HVPG) is not performed routinely before hepatectomy in patients with cirrhosis, although it has been suggested to be useful. This study investigated whether preoperative HVPG values and indirect criteria of portal hypertension (PHT) predict the postoperative course in these patients.
METHODS: Between January 2007 and December 2009, consecutive patients with resectable hepatocellular carcinoma (HCC) in a cirrhotic liver were included in this prospective study. PHT was assessed by transjugular HVPG measurement and by classical indirect criteria (oesophageal varices, splenomegaly and thrombocytopenia). The main endpoints were postoperative liver dysfunction and 90-day mortality.
RESULTS: Forty patients were enrolled. A raised HVPG was associated with postoperative liver dysfunction (median 11 and 7 mmHg in those with and without dysfunction respectively; P = 0·017) and 90-day mortality (12 and 8 mmHg in those who died and survivors respectively; P = 0·026). Oesophageal varices, splenomegaly and thrombocytopenia were not associated with any of the endpoints. In multivariable analysis, body mass index, remnant liver volume ratio and preoperative HVPG were the only independent predictors of postoperative liver dysfunction.
CONCLUSION: An increased HVPG was associated with postoperative liver dysfunction and mortality after liver resection in patients with HCC and liver cirrhosis, whereas indirect criteria of PHT were not. This study suggests that preoperative HVPG measurement should be measured routinely in these patients.
Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22508371     DOI: 10.1002/bjs.8753

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  39 in total

1.  Liver resection for hepatocellular carcinoma in patients with portal hypertension: the role of laparoscopy.

Authors:  Andrea Belli; Luigi Cioffi; Gianluca Russo; Giulio Belli
Journal:  Hepatobiliary Surg Nutr       Date:  2015-12       Impact factor: 7.293

2.  Impact of clinically significant portal hypertension on surgical outcomes for hepatocellular carcinoma in patients with compensated liver cirrhosis: a propensity score matching analysis.

Authors:  Chul Woo Jang; Hyung Jun Kwon; Horyon Kong; Heontak Ha; Young Seok Han; Jae Min Chun; Sang Geol Kim; Yun Jin Hwang
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2016-11-30

Review 3.  Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.

Authors:  Ki Tae Suk; Dong Joon Kim
Journal:  World J Hepatol       Date:  2015-03-27

Review 4.  Laparoscopic liver resection for hepatocellular carcinoma: Indications and role.

Authors:  Adam C Yopp; Amit G Singal
Journal:  Clin Liver Dis (Hoboken)       Date:  2013-01-23

5.  Safety of laparoscopic hepatectomy in patients with hepatocellular carcinoma and portal hypertension: interim analysis of an open prospective study.

Authors:  Chetana Lim; Michael Osseis; Eylon Lahat; Alexandre Doussot; Dobromir Sotirov; Francois Hemery; Marc Lantéri-Minet; Cyrille Feray; Chady Salloum; Daniel Azoulay
Journal:  Surg Endosc       Date:  2018-07-12       Impact factor: 4.584

Review 6.  Treatment Options for Early-Stage Hepatocellular Carcinoma.

Authors:  Nora E Tabori; Gajan Sivananthan
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

7.  Liver resections between 2014 and 2020 in the Lausanne University Hospital, Switzerland.

Authors:  Kosuke Kobayashi; Emilie Uldry; Nicolas Demartines; Nermin Halkic
Journal:  Glob Health Med       Date:  2020-10-31

Review 8.  Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension.

Authors:  Virginia Hernandez-Gea; Fanny Turon; Annalisa Berzigotti; Augusto Villanueva
Journal:  World J Gastroenterol       Date:  2013-02-28       Impact factor: 5.742

9.  Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?

Authors:  Roberto Santambrogio; Michael D Kluger; Mara Costa; Andrea Belli; Matteo Barabino; Alexis Laurent; Enrico Opocher; Daniel Azoulay; Daniel Cherqui
Journal:  HPB (Oxford)       Date:  2012-10-24       Impact factor: 3.647

10.  The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis.

Authors:  Kuan-Chieh Fang; Chien-Wei Su; Yi-You Chiou; Pei-Chang Lee; Nai-Chi Chiu; Chien-An Liu; Ping-Hsien Chen; Wei-Yu Kao; Yi-Hsiang Huang; Teh-Ia Huo; Ming-Chih Hou; Han-Chieh Lin; Jaw-Ching Wu
Journal:  Eur Radiol       Date:  2016-09-27       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.